Agencies working with Russia to set biosimilar standards

05/20/2013 | In-PharmaTechnologist.com

The World Health Organization, national regulatory agencies and international pharmaceutical associations met in Russia to set standards for the manufacture of biologic and biosimiliar products in that country. A key focus is establishing definitions and regulations for biosimilars, which are not yet recognized as distinct products under Russian law.

View Full Article in:

In-PharmaTechnologist.com

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Director of Program Development
AdvaMed
Washington DC, DC
Director of System QA
LifeWatch Services, Inc.
Rosemont, IL
Director of Business Development and Membership
AdvaMed
Washington DC, DC
Vice-President of Technology and Regulatory Affairs
AdvaMed
Washington DC, DC